Microcap company, Kabra Drugs Limited Announces Strategic Expansion into Pharmaceuticals & AI-Driven Defense Technologies
VMPL Chennai (Tamil Nadu) [India], May 7: Kabra Drugs Limited (BSE: 524322), a research-driven pharmaceutical company, yesterday announced in the BSE exchange, a series of strategic initiatives approved by its Board of Directors, marking a significant expansion into pharmaceutical manufacturing, AI-integrated defense technologies, and leadership strengthening. Key Highlights are as below : Pharmaceutical Manufacturing Expansion * Board approved phased expansion…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
 [India]){kind=link}